Barkley PMHNP Mock Certification
Exam II Comprehensive 150-Question
Practice Examination a well detailed
one written and graded A+
upgraded
Instructions
This examination consists of 150 multiple-choice questions designed to assess entry-level
clinical knowledge and skills for the Psychiatric-Mental Health Nurse Practitioner (PMHNP)
certification exam. Questions reflect current psychiatric nursing standards, evidence-based
practice, DSM-5-TR diagnostic criteria, and clinical decision-making. Select the single best
answer for each question. Each question includes a detailed rationale explaining the correct
answer.
Exam Domains Covered:
• Scientific Foundation (Neurobiology, Pathophysiology, Psychopharmacology)
• Psychiatric Assessment and Differential Diagnosis
• Psychotherapy and Therapeutic Interventions
• Ethics, Legal Issues, and Professional Practice
• Lifespan Considerations and Special Populations
,SECTION I: NEUROBIOLOGY AND PATHOPHYSIOLOGY (Questions 1–25)
1. A 28-year-old patient with schizophrenia presents with auditory hallucinations and
paranoid delusions. Which neurotransmitter pathway is primarily implicated in these positive
symptoms?
A. Mesocortical dopaminergic pathway
B. Mesolimbic dopaminergic pathway
C. Nigrostriatal dopaminergic pathway
D. Tuberoinfundibular dopaminergic pathway
Correct Answer: B
Rationale: Positive symptoms of schizophrenia (hallucinations, delusions) are associated with
dopaminergic hyperactivity in the mesolimbic pathway. The mesocortical pathway (A) is
associated with negative and cognitive symptoms. The nigrostriatal pathway (C) is involved in
motor control and is affected by antipsychotic-induced extrapyramidal symptoms. The
tuberoinfundibular pathway (D) regulates prolactin release.
2. A patient with major depressive disorder has been prescribed an SSRI. Which of the
following best describes the mechanism of action of SSRIs?
A. Inhibition of monoamine oxidase enzyme
B. Blockade of presynaptic dopamine reuptake
C. Selective inhibition of serotonin reuptake at the presynaptic terminal
D. Antagonism of postsynaptic serotonin receptors
Correct Answer: C
Rationale: SSRIs selectively inhibit the reuptake of serotonin (5-HT) at the presynaptic neuronal
membrane, increasing serotonin availability in the synaptic cleft. MAOIs (A) inhibit monoamine
oxidase. Dopamine reuptake inhibition (B) is characteristic of bupropion. Receptor antagonism
(D) describes atypical antipsychotics, not SSRIs.
3. Which neurotransmitter is most closely associated with the neurobiology of anxiety
disorders?
A. Dopamine
B. Acetylcholine
,C. Gamma-aminobutyric acid (GABA)
D. Histamine
Correct Answer: C
Rationale: GABA is the primary inhibitory neurotransmitter in the central nervous system.
Dysregulation of GABAergic transmission is implicated in anxiety disorders. Benzodiazepines
enhance GABA activity at GABA-A receptors, producing anxiolytic effects. Dopamine (A) is more
associated with psychosis and reward. Acetylcholine (B) is involved in cognition and memory.
Histamine (D) is primarily involved in arousal and wakefulness.
4. A 55-year-old patient with Parkinson's disease develops visual hallucinations. Which
medication class is most likely contributing to these symptoms?
A. SSRIs
B. Benzodiazepines
C. Dopaminergic agonists
D. Anticholinergics
Correct Answer: C
Rationale: Dopaminergic agonists used in Parkinson's disease can induce hallucinations due to
excessive dopaminergic stimulation. Anticholinergics (D) can cause delirium but are less directly
associated with hallucinations in this context. SSRIs (A) and benzodiazepines (B) are not typically
first-line causes of visual hallucinations in Parkinson's disease.
5. The therapeutic effect of lithium in bipolar disorder is most associated with which of the
following mechanisms?
A. Dopamine receptor blockade
B. Inhibition of inositol monophosphatase and glycogen synthase kinase-3
C. Serotonin reuptake inhibition
D. GABA-A receptor potentiation
Correct Answer: B
Rationale: Lithium's mechanism involves inhibition of inositol monophosphatase and glycogen
synthase kinase-3 (GSK-3), affecting second messenger systems and neuroplasticity. Dopamine
receptor blockade (A) describes antipsychotics. Serotonin reuptake inhibition (C) describes
SSRIs. GABA-A potentiation (D) describes benzodiazepines.
, 6. A patient with Alzheimer's disease is prescribed donepezil. This medication works primarily
through which mechanism?
A. NMDA receptor antagonism
B. Acetylcholinesterase inhibition
C. Dopamine receptor agonism
D. Serotonin receptor modulation
Correct Answer: B
Rationale: Donepezil is a cholinesterase inhibitor that increases acetylcholine availability in the
synaptic cleft by inhibiting its breakdown. NMDA receptor antagonism (A) describes memantine.
Dopamine receptor agonism (C) describes Parkinson's medications. Serotonin modulation (D)
describes antidepressants.
7. Which of the following best describes the role of the hypothalamic-pituitary-adrenal (HPA)
axis in major depressive disorder?
A. Decreased cortisol secretion
B. Hyperactivity of the HPA axis with elevated cortisol
C. Normal HPA axis function with altered serotonin receptors
D. Decreased CRH production
Correct Answer: B
Rationale: Major depressive disorder is associated with HPA axis hyperactivity, resulting in
elevated cortisol levels and impaired feedback inhibition. Decreased cortisol (A) is not
characteristic. Normal HPA function (C) is incorrect as dysregulation is a hallmark. Decreased
CRH (D) is opposite of the observed pathophysiology.
8. A patient with schizophrenia is treated with clozapine. Which receptor affinity profile is
most characteristic of this medication?
A. High D2 affinity, low 5-HT2A affinity
B. Low D2 affinity, high 5-HT2A affinity, and high affinity for multiple other receptors
C. Selective D2 antagonism
D. Selective 5-HT2A antagonism
Correct Answer: B
Exam II Comprehensive 150-Question
Practice Examination a well detailed
one written and graded A+
upgraded
Instructions
This examination consists of 150 multiple-choice questions designed to assess entry-level
clinical knowledge and skills for the Psychiatric-Mental Health Nurse Practitioner (PMHNP)
certification exam. Questions reflect current psychiatric nursing standards, evidence-based
practice, DSM-5-TR diagnostic criteria, and clinical decision-making. Select the single best
answer for each question. Each question includes a detailed rationale explaining the correct
answer.
Exam Domains Covered:
• Scientific Foundation (Neurobiology, Pathophysiology, Psychopharmacology)
• Psychiatric Assessment and Differential Diagnosis
• Psychotherapy and Therapeutic Interventions
• Ethics, Legal Issues, and Professional Practice
• Lifespan Considerations and Special Populations
,SECTION I: NEUROBIOLOGY AND PATHOPHYSIOLOGY (Questions 1–25)
1. A 28-year-old patient with schizophrenia presents with auditory hallucinations and
paranoid delusions. Which neurotransmitter pathway is primarily implicated in these positive
symptoms?
A. Mesocortical dopaminergic pathway
B. Mesolimbic dopaminergic pathway
C. Nigrostriatal dopaminergic pathway
D. Tuberoinfundibular dopaminergic pathway
Correct Answer: B
Rationale: Positive symptoms of schizophrenia (hallucinations, delusions) are associated with
dopaminergic hyperactivity in the mesolimbic pathway. The mesocortical pathway (A) is
associated with negative and cognitive symptoms. The nigrostriatal pathway (C) is involved in
motor control and is affected by antipsychotic-induced extrapyramidal symptoms. The
tuberoinfundibular pathway (D) regulates prolactin release.
2. A patient with major depressive disorder has been prescribed an SSRI. Which of the
following best describes the mechanism of action of SSRIs?
A. Inhibition of monoamine oxidase enzyme
B. Blockade of presynaptic dopamine reuptake
C. Selective inhibition of serotonin reuptake at the presynaptic terminal
D. Antagonism of postsynaptic serotonin receptors
Correct Answer: C
Rationale: SSRIs selectively inhibit the reuptake of serotonin (5-HT) at the presynaptic neuronal
membrane, increasing serotonin availability in the synaptic cleft. MAOIs (A) inhibit monoamine
oxidase. Dopamine reuptake inhibition (B) is characteristic of bupropion. Receptor antagonism
(D) describes atypical antipsychotics, not SSRIs.
3. Which neurotransmitter is most closely associated with the neurobiology of anxiety
disorders?
A. Dopamine
B. Acetylcholine
,C. Gamma-aminobutyric acid (GABA)
D. Histamine
Correct Answer: C
Rationale: GABA is the primary inhibitory neurotransmitter in the central nervous system.
Dysregulation of GABAergic transmission is implicated in anxiety disorders. Benzodiazepines
enhance GABA activity at GABA-A receptors, producing anxiolytic effects. Dopamine (A) is more
associated with psychosis and reward. Acetylcholine (B) is involved in cognition and memory.
Histamine (D) is primarily involved in arousal and wakefulness.
4. A 55-year-old patient with Parkinson's disease develops visual hallucinations. Which
medication class is most likely contributing to these symptoms?
A. SSRIs
B. Benzodiazepines
C. Dopaminergic agonists
D. Anticholinergics
Correct Answer: C
Rationale: Dopaminergic agonists used in Parkinson's disease can induce hallucinations due to
excessive dopaminergic stimulation. Anticholinergics (D) can cause delirium but are less directly
associated with hallucinations in this context. SSRIs (A) and benzodiazepines (B) are not typically
first-line causes of visual hallucinations in Parkinson's disease.
5. The therapeutic effect of lithium in bipolar disorder is most associated with which of the
following mechanisms?
A. Dopamine receptor blockade
B. Inhibition of inositol monophosphatase and glycogen synthase kinase-3
C. Serotonin reuptake inhibition
D. GABA-A receptor potentiation
Correct Answer: B
Rationale: Lithium's mechanism involves inhibition of inositol monophosphatase and glycogen
synthase kinase-3 (GSK-3), affecting second messenger systems and neuroplasticity. Dopamine
receptor blockade (A) describes antipsychotics. Serotonin reuptake inhibition (C) describes
SSRIs. GABA-A potentiation (D) describes benzodiazepines.
, 6. A patient with Alzheimer's disease is prescribed donepezil. This medication works primarily
through which mechanism?
A. NMDA receptor antagonism
B. Acetylcholinesterase inhibition
C. Dopamine receptor agonism
D. Serotonin receptor modulation
Correct Answer: B
Rationale: Donepezil is a cholinesterase inhibitor that increases acetylcholine availability in the
synaptic cleft by inhibiting its breakdown. NMDA receptor antagonism (A) describes memantine.
Dopamine receptor agonism (C) describes Parkinson's medications. Serotonin modulation (D)
describes antidepressants.
7. Which of the following best describes the role of the hypothalamic-pituitary-adrenal (HPA)
axis in major depressive disorder?
A. Decreased cortisol secretion
B. Hyperactivity of the HPA axis with elevated cortisol
C. Normal HPA axis function with altered serotonin receptors
D. Decreased CRH production
Correct Answer: B
Rationale: Major depressive disorder is associated with HPA axis hyperactivity, resulting in
elevated cortisol levels and impaired feedback inhibition. Decreased cortisol (A) is not
characteristic. Normal HPA function (C) is incorrect as dysregulation is a hallmark. Decreased
CRH (D) is opposite of the observed pathophysiology.
8. A patient with schizophrenia is treated with clozapine. Which receptor affinity profile is
most characteristic of this medication?
A. High D2 affinity, low 5-HT2A affinity
B. Low D2 affinity, high 5-HT2A affinity, and high affinity for multiple other receptors
C. Selective D2 antagonism
D. Selective 5-HT2A antagonism
Correct Answer: B
